GENFIT (EPA:GNFT) | Finanzwire

BRIEF

published on 05/05/2025 at 07:35, 11 months 27 days ago

GENFIT to Showcase ACLF Research at EASL Congress 2025

Biopharmaceutical GENFIT EASL Congress ACLF Research Hepatology
PRESS RELEASE

published on 05/05/2025 at 07:30, 11 months 27 days ago

GENFIT to Present Latest ACLF Research at EASL Congress 2025
GENFIT to Present Latest ACLF Research at EASL Congress 2025. Six posters on ACLF and diagnostic models. Events include EASL Studio and ACLF Patient Advocacy Council session

Research GENFIT ACLF EASL Congress Posters
BRIEF

published on 04/29/2025 at 21:15, 1 year ago

GENFIT Publishes its 2024 Annual Reports

Annual Report Biopharmaceuticals Registration Document Liver Diseases GENFIT
PRESS RELEASE

published on 04/29/2025 at 21:10, 1 year ago

GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F
GENFIT announces filing of 2024 Universal Registration Document and Annual Report on Form 20-F with AMF and SEC, available for public viewing and download. Details of reports and company's focus on liver disease research and development highlighted

2024 Universal Registration Document Form 20-F Liver Diseases GENFIT
BRIEF

published on 04/28/2025 at 22:15, 1 year ago

GENFIT's Positive Phase 2 Results for Elafibranor in PSC Announced

GENFIT Phase 2 Results Elafibranor PSC EASL Congress 2025
PRESS RELEASE

published on 04/28/2025 at 22:10, 1 year ago

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025
GENFIT announces positive Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented at EASL Congress 2025 by Ipsen, showing significant efficacy and safety profile improvements

GENFIT EASL Congress Elafibranor Phase 2 Data Primary Sclerosing Cholangitis
PRESS RELEASE

published on 04/24/2025 at 22:10, 1 year ago

GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update
GENFIT reports full-year 2024 financial results and corporate update. Net profit of €1.5 million, Iqirvo® commercial launch in PBC, new ACLF datasets, royalty financing. CEO, Pascal Prigent shares progress and outlook

Financial Results GENFIT ACLF Iqirvo® Full-year 2024
BRIEF

published on 03/10/2025 at 22:15, 1 year 1 month ago

GENFIT's Bondholders Approve Amendments for 2025 OCEANEs Royalty Financing

Bondholders Amendments Royalty Financing GENFIT OCEANEs
PRESS RELEASE

published on 03/10/2025 at 22:10, 1 year 1 month ago

Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs
GENFIT's 2025 OCEANEs bondholders approve amendment of terms & conditions, anticipates Royalty Financing closure. Repurchase & Consent Fee details announced

Repurchase Bondholders Royalty Financing GENFIT 2025 OCEANEs
BRIEF

published on 02/27/2025 at 22:15, 1 year 2 months ago

GENFIT Reports Financial Metrics for 2024

Revenue Growth Cash Position Strategic Partnership Milestone Payment GENFIT Financials 2024

Published on 05/02/2026 at 00:50, 12 minutes ago

CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 hour 2 minutes ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 hour 2 minutes ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 2 hours 32 minutes ago

Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 22:30, 2 hours 32 minutes ago

Integrated Rewards Achieves SOC 2 Compliance to Support Enterprise-Scale Growth Across Canada's Card-Linked Rewards Network as EQ Closes Convertible Debt Financing

View all ACCESSWIRE

Published on 05/01/2026 at 19:23, 5 hours 39 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 6 hours 22 minutes ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 7 hours 15 minutes ago

Key Figures 30.04.2026
Published on 05/01/2026 at 17:45, 7 hours 17 minutes ago

Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 7 hours 40 minutes ago

Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

View all EQS

Published on 04/30/2026 at 20:00, 1 day 5 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 5 hours ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 6 hours ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 6 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 1 day 7 hours ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News